Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study
We aimed to investigate the effectiveness of articaine and perineural dexamethasone (DX) in reducing postoperative sequelae such as swelling and maximum mouth opening that are harming the quality of life of patients after impacted mandibular third molar (IMTM) surgery. We implemented a randomized cl...
Gespeichert in:
Veröffentlicht in: | Journal of oral and maxillofacial surgery 2020-04, Vol.78 (4), p.507-514 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 514 |
---|---|
container_issue | 4 |
container_start_page | 507 |
container_title | Journal of oral and maxillofacial surgery |
container_volume | 78 |
creator | Atalay, Berkem Şitilci, Abdullah Tolga Onur, Özen Doğan |
description | We aimed to investigate the effectiveness of articaine and perineural dexamethasone (DX) in reducing postoperative sequelae such as swelling and maximum mouth opening that are harming the quality of life of patients after impacted mandibular third molar (IMTM) surgery.
We implemented a randomized clinical trial composed of patients undergoing IMTM extraction. The predictor variable was the treatment group. The patients were randomly assigned to 1 of 3 groups: Group A was administered 3.6 mL of articaine mixed with 2 mL of saline solution; group B, 3.6 mL of articaine and 1 mL of DX (4-mg/mL solution) with 1 mL of saline solution; and group C, 3.6 mL of articaine with 2 mL of DX (8-mg/mL solution). The primary outcome variables were swelling (determined by anatomic facial landmarks), pain, and maximum mouth opening. Other variables comprised the duration of surgery, number of analgesics taken in the postoperative period, hygiene, and petechiae.
The sample was composed of 60 patients (20 per treatment group), with a mean age of 25.18 ± 5.22 years; 53.3% were women. Postoperative swelling was significantly reduced in groups B and C (P |
doi_str_mv | 10.1016/j.joms.2019.10.024 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2320378281</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278239119312522</els_id><sourcerecordid>2320378281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-92e50df47a7276448f1859b0c03c55d790f736ae537ad03b488c58fbd895bc13</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EotvCC3BAPnIgi__EawdxCW2BSq1AdO-WY49br5K4tRPE9kF4Xhy2cOQ0n2Z-80kzH0KvKFlTQjfvdutdHPKaEdqUxpqw-glaUcFpJYjgT9GKMKkqxht6hI5z3hFCqZCb5-iIU6k4IfUK_WpH099ADhab0eF2nEJ1MfreDIOZYtrjc-_BThlHj9s0BWvCCH_Qb5CKnJPp8Rn8NANMtybHMvQx4atChG7uTcLb25AcvoqLvp7TDaT9e9zi74WIQ3gA9xafxbnrofrYh-J7Pc1u_wI986bP8PKxnqDtp_Pt6Zfq8uvni9P2srI1IVPVMBDE-VoayeSmrpWnSjQdsYRbIZxsiJd8Y0BwaRzhXa2UFcp3TjWis5SfoDcH27sU72fIkx5CttD3ZoQ4Z804I1wqphaUHVCbYs4JvL5LYTBprynRSxx6p5c49BLH0itxlKXXj_5zN4D7t_L3_wX4cACgHPkjQNLZBhgtuJDK27WL4X_-vwH_5pz4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2320378281</pqid></control><display><type>article</type><title>Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study</title><source>Elsevier ScienceDirect Journals</source><creator>Atalay, Berkem ; Şitilci, Abdullah Tolga ; Onur, Özen Doğan</creator><creatorcontrib>Atalay, Berkem ; Şitilci, Abdullah Tolga ; Onur, Özen Doğan</creatorcontrib><description>We aimed to investigate the effectiveness of articaine and perineural dexamethasone (DX) in reducing postoperative sequelae such as swelling and maximum mouth opening that are harming the quality of life of patients after impacted mandibular third molar (IMTM) surgery.
We implemented a randomized clinical trial composed of patients undergoing IMTM extraction. The predictor variable was the treatment group. The patients were randomly assigned to 1 of 3 groups: Group A was administered 3.6 mL of articaine mixed with 2 mL of saline solution; group B, 3.6 mL of articaine and 1 mL of DX (4-mg/mL solution) with 1 mL of saline solution; and group C, 3.6 mL of articaine with 2 mL of DX (8-mg/mL solution). The primary outcome variables were swelling (determined by anatomic facial landmarks), pain, and maximum mouth opening. Other variables comprised the duration of surgery, number of analgesics taken in the postoperative period, hygiene, and petechiae.
The sample was composed of 60 patients (20 per treatment group), with a mean age of 25.18 ± 5.22 years; 53.3% were women. Postoperative swelling was significantly reduced in groups B and C (P < .05). Maximum mouth opening was significantly increased in groups B and C (P < .05).
The results of this study suggest that combining DX with articaine improves the management of discomfort after IMTM surgery. The use of articaine via a mandibular block was not associated with neural damage in our study.</description><identifier>ISSN: 0278-2391</identifier><identifier>EISSN: 1531-5053</identifier><identifier>DOI: 10.1016/j.joms.2019.10.024</identifier><identifier>PMID: 31783004</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Dentistry</subject><ispartof>Journal of oral and maxillofacial surgery, 2020-04, Vol.78 (4), p.507-514</ispartof><rights>2019 American Association of Oral and Maxillofacial Surgeons</rights><rights>Copyright © 2019 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-92e50df47a7276448f1859b0c03c55d790f736ae537ad03b488c58fbd895bc13</citedby><cites>FETCH-LOGICAL-c400t-92e50df47a7276448f1859b0c03c55d790f736ae537ad03b488c58fbd895bc13</cites><orcidid>0000-0003-3813-7398</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0278239119312522$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31783004$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Atalay, Berkem</creatorcontrib><creatorcontrib>Şitilci, Abdullah Tolga</creatorcontrib><creatorcontrib>Onur, Özen Doğan</creatorcontrib><title>Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study</title><title>Journal of oral and maxillofacial surgery</title><addtitle>J Oral Maxillofac Surg</addtitle><description>We aimed to investigate the effectiveness of articaine and perineural dexamethasone (DX) in reducing postoperative sequelae such as swelling and maximum mouth opening that are harming the quality of life of patients after impacted mandibular third molar (IMTM) surgery.
We implemented a randomized clinical trial composed of patients undergoing IMTM extraction. The predictor variable was the treatment group. The patients were randomly assigned to 1 of 3 groups: Group A was administered 3.6 mL of articaine mixed with 2 mL of saline solution; group B, 3.6 mL of articaine and 1 mL of DX (4-mg/mL solution) with 1 mL of saline solution; and group C, 3.6 mL of articaine with 2 mL of DX (8-mg/mL solution). The primary outcome variables were swelling (determined by anatomic facial landmarks), pain, and maximum mouth opening. Other variables comprised the duration of surgery, number of analgesics taken in the postoperative period, hygiene, and petechiae.
The sample was composed of 60 patients (20 per treatment group), with a mean age of 25.18 ± 5.22 years; 53.3% were women. Postoperative swelling was significantly reduced in groups B and C (P < .05). Maximum mouth opening was significantly increased in groups B and C (P < .05).
The results of this study suggest that combining DX with articaine improves the management of discomfort after IMTM surgery. The use of articaine via a mandibular block was not associated with neural damage in our study.</description><subject>Dentistry</subject><issn>0278-2391</issn><issn>1531-5053</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxi0EotvCC3BAPnIgi__EawdxCW2BSq1AdO-WY49br5K4tRPE9kF4Xhy2cOQ0n2Z-80kzH0KvKFlTQjfvdutdHPKaEdqUxpqw-glaUcFpJYjgT9GKMKkqxht6hI5z3hFCqZCb5-iIU6k4IfUK_WpH099ADhab0eF2nEJ1MfreDIOZYtrjc-_BThlHj9s0BWvCCH_Qb5CKnJPp8Rn8NANMtybHMvQx4atChG7uTcLb25AcvoqLvp7TDaT9e9zi74WIQ3gA9xafxbnrofrYh-J7Pc1u_wI986bP8PKxnqDtp_Pt6Zfq8uvni9P2srI1IVPVMBDE-VoayeSmrpWnSjQdsYRbIZxsiJd8Y0BwaRzhXa2UFcp3TjWis5SfoDcH27sU72fIkx5CttD3ZoQ4Z804I1wqphaUHVCbYs4JvL5LYTBprynRSxx6p5c49BLH0itxlKXXj_5zN4D7t_L3_wX4cACgHPkjQNLZBhgtuJDK27WL4X_-vwH_5pz4</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Atalay, Berkem</creator><creator>Şitilci, Abdullah Tolga</creator><creator>Onur, Özen Doğan</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3813-7398</orcidid></search><sort><creationdate>202004</creationdate><title>Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study</title><author>Atalay, Berkem ; Şitilci, Abdullah Tolga ; Onur, Özen Doğan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-92e50df47a7276448f1859b0c03c55d790f736ae537ad03b488c58fbd895bc13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Dentistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Atalay, Berkem</creatorcontrib><creatorcontrib>Şitilci, Abdullah Tolga</creatorcontrib><creatorcontrib>Onur, Özen Doğan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of oral and maxillofacial surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Atalay, Berkem</au><au>Şitilci, Abdullah Tolga</au><au>Onur, Özen Doğan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study</atitle><jtitle>Journal of oral and maxillofacial surgery</jtitle><addtitle>J Oral Maxillofac Surg</addtitle><date>2020-04</date><risdate>2020</risdate><volume>78</volume><issue>4</issue><spage>507</spage><epage>514</epage><pages>507-514</pages><issn>0278-2391</issn><eissn>1531-5053</eissn><abstract>We aimed to investigate the effectiveness of articaine and perineural dexamethasone (DX) in reducing postoperative sequelae such as swelling and maximum mouth opening that are harming the quality of life of patients after impacted mandibular third molar (IMTM) surgery.
We implemented a randomized clinical trial composed of patients undergoing IMTM extraction. The predictor variable was the treatment group. The patients were randomly assigned to 1 of 3 groups: Group A was administered 3.6 mL of articaine mixed with 2 mL of saline solution; group B, 3.6 mL of articaine and 1 mL of DX (4-mg/mL solution) with 1 mL of saline solution; and group C, 3.6 mL of articaine with 2 mL of DX (8-mg/mL solution). The primary outcome variables were swelling (determined by anatomic facial landmarks), pain, and maximum mouth opening. Other variables comprised the duration of surgery, number of analgesics taken in the postoperative period, hygiene, and petechiae.
The sample was composed of 60 patients (20 per treatment group), with a mean age of 25.18 ± 5.22 years; 53.3% were women. Postoperative swelling was significantly reduced in groups B and C (P < .05). Maximum mouth opening was significantly increased in groups B and C (P < .05).
The results of this study suggest that combining DX with articaine improves the management of discomfort after IMTM surgery. The use of articaine via a mandibular block was not associated with neural damage in our study.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31783004</pmid><doi>10.1016/j.joms.2019.10.024</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3813-7398</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0278-2391 |
ispartof | Journal of oral and maxillofacial surgery, 2020-04, Vol.78 (4), p.507-514 |
issn | 0278-2391 1531-5053 |
language | eng |
recordid | cdi_proquest_miscellaneous_2320378281 |
source | Elsevier ScienceDirect Journals |
subjects | Dentistry |
title | Analgesic and Anti-Inflammatory Effects of Articaine and Perineural Dexamethasone for Mandibular Third Molar Surgery: A Randomized, Double-Blind Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T21%3A00%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analgesic%20and%20Anti-Inflammatory%20Effects%20of%20Articaine%20and%20Perineural%20Dexamethasone%20for%20Mandibular%20Third%20Molar%20Surgery:%20A%20Randomized,%20Double-Blind%20Study&rft.jtitle=Journal%20of%20oral%20and%20maxillofacial%20surgery&rft.au=Atalay,%20Berkem&rft.date=2020-04&rft.volume=78&rft.issue=4&rft.spage=507&rft.epage=514&rft.pages=507-514&rft.issn=0278-2391&rft.eissn=1531-5053&rft_id=info:doi/10.1016/j.joms.2019.10.024&rft_dat=%3Cproquest_cross%3E2320378281%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2320378281&rft_id=info:pmid/31783004&rft_els_id=S0278239119312522&rfr_iscdi=true |